Marketing Approval for Zetiq's CellDetect® in China

 

Micromedic announced that the product CellDetect®, manufactured by Zetiq - a subsidiary under the full control of Micromedic, designed to diagnose cancerous cells in the cervix, has been approved by the State Food and Drug Administration (SFDA) of the People’s Republic of China for marketing in China.

Link to complete article

More News/Information
© Micromedic Technologies Ltd. site mapcontact
 
Site by Site2goal | Design Studio Michal Lehavi